Cargando…

LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin

BACKGROUND: Fournier's gangrene (FG) is a form of necrotizing fasciitis characterized by polymicrobial infection of the perineal, perianal or genital areas; risk factors include diabetes mellitus and male gender. Dapagliflozin is one of four sodium-glucose cotransporter 2 (SGLT2) inhibitors FDA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Janki M, Shah, Parth, Shah, Love S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629238/ http://dx.doi.org/10.1210/jendso/bvac150.599

Ejemplares similares

PSUN259 A Severe Case of Fournier's Gangrene Associated With Dapagliflozin
por: Syed, Shumail, et al.
Publicado: (2022)

LBSUN213 An Investigation Into The Effects Of Dapagliflozin On Ketogenesis In Type 1 Diabetes
por: Ghanim, Husam, et al.
Publicado: (2022)

SUN-700 Fournier’s Gangrene and Diabetic Ketoacidosis Caused by Canagliflozin
por: Stamatiades, George Alexiades, et al.
Publicado: (2020)

THU282 Improved Fournier’s Gangrene Outcomes With Prior SGLT2i Or Metformin Usage
por: Venugopal, Sharini, et al.
Publicado: (2023)

LBSUN151 The Impact Of The COVID-19 Pandemic On Diabetes & Weight Management
por: Hashmi, Hiba Z, et al.
Publicado: (2022)

RF16 | PSUN170 Prevalence of Fournier's Gangrene in T2DM Treated with Oral Antiglycemic Medications
por: Engel, Ashley, et al.
Publicado: (2022)

LBSUN180 Preconception Counseling And Reproductive Education Program For People With Diabetes (PREPP'D) - An Educational Program For Underserved Women With Diabetes
por: Wang, Ally W, et al.
Publicado: (2022)

LBSUN331 Rescuing Alpha Cell Responses To Hypoglycemia In Type 1 Diabetes
por: Panzer, Julia, et al.
Publicado: (2022)

LBSUN209 A Novel Algorithm For The Management Of Inpatient Covid-19 Steroid-induced Hyperglycemia
por: Karol, Alexander B, et al.
Publicado: (2022)

LBSUN321 Development And Pilot Testing Of Barriers To Diabetic Foot Care With A Qualitative Assessment
por: Blanco, Gerardo, et al.
Publicado: (2022)

LBSUN208 Patient Education And Addressal Of Social Determinants Of Health: Key To Improvement In Diabetes Care
por: Manas, F N U, et al.
Publicado: (2022)

LBSUN309 The Effect Of Prebiotics In Newly Diagnosed Youth With Type 1 Diabetes (T1D)
por: Ismail, Heba, et al.
Publicado: (2022)

LBSUN152 The Warburg Effect And Complex Thermomics Inform Phenotypic Expression
por: Fredericks, Robert S
Publicado: (2022)

LBSUN205 Clinical Practice Guidelines With Education Make A Difference
por: Mohieldin, Mohamed Elfatih
Publicado: (2022)

LBSUN178 Teniposide Improves Adeno-associated Virus-mediated Insulin Gene Therapy In Diabetic Mice.
por: Akcan, Tugce, et al.
Publicado: (2022)

LBSUN211 The Importance Of Early Opportunities To Identify And Treat Prediabetes Or Even Change The Diagnostic Threshold For Diabetes
por: Schwartz, Stanley S, et al.
Publicado: (2022)

LBSUN149 Effectiveness Of Digital Twin Technology For The Improvement In Depression Among Patients Undergoing Remission Of Diabetes
por: Shashank, Joshi, et al.
Publicado: (2022)

LBSUN214 Accuracy Of A Continuous Glucose Monitor In The Intensive Care Unit
por: Bann, Sewon, et al.
Publicado: (2022)

LBSUN154 Baseline Albuminuria May Protect Against Severe Covid-19 In Type 2 Diabetes Patients
por: Bashkin, Amir, et al.
Publicado: (2022)

ODP604 | LBSUN287 Ketosis-prone Type 2 Diabetes (Flatbush Diabetes) In Remission: Report Of Two Cases
por: Ji, Beisi, et al.
Publicado: (2022)

LBSUN332 A Novel Drug To Modulate Auto-inflammation And Promote Glucose Control In Type 1 Diabetes Mellitus
por: Wagner, David, et al.
Publicado: (2022)

LBSUN215 Evaluation Of Glycemic Control By Continuous Glucose Monitoring Among Hospitalized Older Adults With Type-2 Diabetes And Frailty
por: Idrees, Thaer, et al.
Publicado: (2022)

LBSUN292 Learning Lesson From A Case of Fulminant Type 1 Diabetes Mellitus Shortly After Pembrolizumab Treatment
por: Phan, Van, et al.
Publicado: (2022)

LBSUN307 A Randomized Controlled Pilot Study Of The Food Order Behavioral Intervention In Prediabetes
por: Shukla, Alpana P, et al.
Publicado: (2022)

LBSUN206 Provider Prescribing Habits And Use Of Newer Agents For Type 2 Diabetes In A Large Multicenter Health Care System
por: Yaseen, Aseel, et al.
Publicado: (2022)

LBSUN161 Relationship Of Shape Of Glucose OGTT Curves With Measures Of Cardiometabolic Health In African American Adolescents
por: Thaker, Vidhu, et al.
Publicado: (2022)

LBSUN288 Improved Glycemic Control Following Oophorectomy In A Post-menopausal Woman With Ovarian Hyperthecosis
por: Learned, Brooke Noelle, et al.
Publicado: (2022)

LBSUN294 Insulin-induced Abdominal Acanthosis Nigricans From High Doses Of Insulin U-500
por: Yap, Sara Elizabeth, et al.
Publicado: (2022)

LBSUN153 Trends In Diabetic Emergencies, A1c Monitoring And Telemedicine Utilization During The Covid Pandemic - A Cross Sectional Study
por: Kennedy, Randol, et al.
Publicado: (2022)

LBSUN320 Building The Evidence To Address Disparities In Type 1 Diabetes (BEAD-T1D): Recruitment Practices To Engage Underrepresented Youth And Their Families
por: Peñaranda, Ricardo Medina, et al.
Publicado: (2022)

LBSUN319 Characteristics And Treatment Patterns Of Hispanic/latino Patients Initiating First Injectable Glp-1ra Or Basal Insulin
por: Hoog, Meredith, et al.
Publicado: (2022)

THU291 Successful Reversal Of Glucose Toxicity After DKA Precipitated By SGLT2 Inhibitor
por: Abdelrahman, Houda, et al.
Publicado: (2023)

LBSUN306 Effects Of Glp-1 Receptor Agonism, Dpp4 Inhibition, And Hypocaloric Diet On Metabolic Parameters In Obese Pre-diabetic Individuals: A Randomized-controlled Trial
por: Mashayekhi, Mona, et al.
Publicado: (2022)

LBSUN210 Efficacy And Safety Profile Of Insulin Icodec Versus Insulin Glargine U100 In Type 2 Diabetes Mellitus: A Meta-Analysis Of Randomized Controlled Trials
por: Dimayuga, Diana Colleen, et al.
Publicado: (2022)

LBSUN289 Ketonuria — A Possible Early Indicator Of Impending Euglycemic DKA In Setting Of Recent SGLT-2 Inhibitor Use And Acute Stress
por: Arora, Gunjan, et al.
Publicado: (2022)

LBSUN162 Cumulative Probability Of Heart Failure Hospitalization Among Non-Hispanic Black Compared To Non-Hispanic White Individuals With Type 2 Diabetes On Empagliflozin (EMPA-AA): Real-world Data
por: Mishriky, Basem M, et al.
Publicado: (2022)

THU255 Tirzepatide-induced Weight Loss In A Type 2 Diabetic Taking Oral Contraceptives
por: Arunachalam, Amar, et al.
Publicado: (2023)

LBSUN290 A Rare, Sordid Tale Of The Two Most Dreaded Adverse Effects Of SGLT-2 Inhibitors Occurring Concurrently - Acute Pancreatitis And Euglycemic Diabetic Ketoacidosis - Within Days Of Initiating Empagliflozin Therapy.
por: Arora, Gunjan, et al.
Publicado: (2022)

LBSUN207 Efficacy And Safety Of Degludec U100 Versus Glargine U300 For The Hospital Management Of Patients With Type 2 Diabetes: A Prospective, Open-label, Non-inferiority Randomized Controlled Trial
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2022)

Fournier’s Gangrene: A Coexistence or Consanguinity of SGLT-2 Inhibitor Therapy
por: Chowdhury, Tutul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7q0r7nrepfrkckbhbd42504p7h